DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma
Advanced Science · 2024
DOI: 10.1002/advs.202403262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Qing-Jie Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong …. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Ubiquitin Thiolesterase, Drug Resistance, Neoplasm, RNA Recognition Motif Proteins. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Despite docetaxel combined with cisplatin and 5‐fluorouracil (TPF) being the established treatment for advanced nasopharyngeal carcinoma (NPC), there are patients who do not respond positively to this form of therapy. However, the mechanisms underlying this lack of benefit remain unclear. DCAF7 is identified as a chemoresistance gene attenuating the response to TPF therapy in NPC patients. DCAF7 promotes the cisplatin resistance and metastasis of NPC cells in vitro and in vivo. Mechanistically, DCAF7 serves as a scaffold protein that facilitates the interaction between USP10 and G3BP1, leading to the elimination of K48‐linked ubiquitin moieties from Lys76 of G3BP1. This process helps prevent the degradation of G3BP1 via the ubiquitin‒proteasome pathway and promotes the formation of stress granule (SG)‐like structures. Moreover, knockdown of G3BP1 successfully reversed the formation of SG‐like structures and the oncogenic effects of DCAF7. Significantly, NPC patients with increased levels of DCAF7 showed a high risk of metastasis, and elevated DCAF7 levels are linked to an unfavorable prognosis. The study reveals DCAF7 as a crucial gene for cisplatin resistance and offers further understanding of how chemoresistance develops in NPC. The DCAF7‐USP10‐G3BP1 axis contains potential targets and biomarkers for NPC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651…
ORCID-Profile: Yin Zhao, Ling-Long Tang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, Q. J., Fang, X. L., Li, Y. Q., Lin, J. Y., Huang, C. L., He, S. W., Huang, S. Y., Li, J. Y., Gong, S., Liu, N., Ma, J., Zhao, Y., & Tang, L. L. (2024). DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202403262
Vancouver
Li QJ, Fang XL, Li YQ, Lin JY, Huang CL, He SW, et al. DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma. Advanced Science. 2024. doi:10.1002/advs.202403262
BibTeX
@article{Li2024,
author = {Li, Qing-Jie and Fang, Xue-Liang and Li, Ying-Qin and Lin, Jia-Yi and Huang, Cheng-Long and He, Shi-Wei and Huang, Sheng-Yan and Li, Jun-Yan and Gong, Sha and Liu, Na and Ma, Jun and Zhao, Yin and Tang, Ling-Long},
title = {DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202403262}
}
EUVIMED